[Serum activity of leucine aminopeptidase in lymphotropic infections and in malignant lymphomas].
Increases of the leucine aminopeptidase according to data of literature are regarded as a sensitive parameter of lesions in liver diseases. In patients with active generalised lymphadenitis (viral infections, toxoplasmosis) as a typical enzyme constellation a relatively strong leucine aminopeptidase increase in the serum with missing or relatively slight enzyme deviation of the transaminases could be found. The quotient of the activities of LAP/ALAT was clearly above that of inflammatory liver diseases. In chronic lymphatic leukosis, plasmocytoma and malignant lymphomas the leucine aminopeptidase serum activities were within the normal. Increases of leucine aminopeptidase in lymphotropic infections are probably partly of extrahepatic origin.
D006801:Humans; D007931:Leucyl Aminopeptidase / Q000378:metabolism*; D008199:Lymphadenitis / Q000201:enzymology*; D008223:Lymphoma / Q000201:enzymology*; D000637:Transaminases / Q000378:metabolism; D014777:Virus Diseases / Q000201:enzymology
D000637:Transaminases; D007931:Leucyl Aminopeptidase
Die Serumaktivität der Leuzinaminopeptidase bei lymphotropen Infektionen und malignen Lymphomen.